Dr Curt J Heimbach, MD | |
8260 Atlee Rd, Mechanicsville, VA 23116-1844 | |
(804) 764-6111 | |
Not Available |
Full Name | Dr Curt J Heimbach |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 21 Years |
Location | 8260 Atlee Rd, Mechanicsville, Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588609465 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 0101239706 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Rappahannock General Hospital | Kilmarnock, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Emergency Medicine Associates Pa Pc | 8022914522 | 382 |
News Archive
The study showed that about thirty percent to maybe half of the leading causes of death in the world are preventable. These are risk factors that you could manage and thus you could prevent a lot of premature deaths.
Precautionary health measures such as mammograms and cholesterol tests that identify the risk of heart disease are critical for the well-being of women over 50.
Rapid increase in output from second-generation DNA sequencers has enabled new levels of productivity and new experiments. This, along with funding from the stimulus bill, has caused rapid adoption of these machines, according to healthcare market research firm Kalorama Information, helping to fuel sales of DNA sequencers to $480 million in 2008. In its report "DNA Sequencing Equipment and Services Markets, 2nd Edition," Kalorama says more changes are on the way and will drives sales growth of 19% annually through 2013.
The Washington Post reports on a health care battle between a hospital and insurers that is leaving patients caught in the middle. At Bayonne Medical Center in New Jersey, Horizon Blue Cross Blue Shield delivered letters to patients at the hospital "warning that the patient would face a huge hospital bill if he did not leave right away."
For the 29,000 patients in the United States with metastatic colorectal cancer, chemotherapy with irinotecan is a standard treatment that has been shown to improve survival. But for more than one in 10 of these patients, a variation in their DNA means that this treatment could result in a severe reduction in their white blood cell count, leading to a high risk of bacterial infection and possible subsequent death.
› Verified 4 days ago
Entity Name | Emergency Medicine Associates Pa Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134117393 PECOS PAC ID: 8022914522 Enrollment ID: O20031208000283 |
News Archive
The study showed that about thirty percent to maybe half of the leading causes of death in the world are preventable. These are risk factors that you could manage and thus you could prevent a lot of premature deaths.
Precautionary health measures such as mammograms and cholesterol tests that identify the risk of heart disease are critical for the well-being of women over 50.
Rapid increase in output from second-generation DNA sequencers has enabled new levels of productivity and new experiments. This, along with funding from the stimulus bill, has caused rapid adoption of these machines, according to healthcare market research firm Kalorama Information, helping to fuel sales of DNA sequencers to $480 million in 2008. In its report "DNA Sequencing Equipment and Services Markets, 2nd Edition," Kalorama says more changes are on the way and will drives sales growth of 19% annually through 2013.
The Washington Post reports on a health care battle between a hospital and insurers that is leaving patients caught in the middle. At Bayonne Medical Center in New Jersey, Horizon Blue Cross Blue Shield delivered letters to patients at the hospital "warning that the patient would face a huge hospital bill if he did not leave right away."
For the 29,000 patients in the United States with metastatic colorectal cancer, chemotherapy with irinotecan is a standard treatment that has been shown to improve survival. But for more than one in 10 of these patients, a variation in their DNA means that this treatment could result in a severe reduction in their white blood cell count, leading to a high risk of bacterial infection and possible subsequent death.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Curt J Heimbach, MD Po Box 3648, Williamsburg, VA 23187-3648 Ph: (757) 221-7111 | Dr Curt J Heimbach, MD 8260 Atlee Rd, Mechanicsville, VA 23116-1844 Ph: (804) 764-6111 |
News Archive
The study showed that about thirty percent to maybe half of the leading causes of death in the world are preventable. These are risk factors that you could manage and thus you could prevent a lot of premature deaths.
Precautionary health measures such as mammograms and cholesterol tests that identify the risk of heart disease are critical for the well-being of women over 50.
Rapid increase in output from second-generation DNA sequencers has enabled new levels of productivity and new experiments. This, along with funding from the stimulus bill, has caused rapid adoption of these machines, according to healthcare market research firm Kalorama Information, helping to fuel sales of DNA sequencers to $480 million in 2008. In its report "DNA Sequencing Equipment and Services Markets, 2nd Edition," Kalorama says more changes are on the way and will drives sales growth of 19% annually through 2013.
The Washington Post reports on a health care battle between a hospital and insurers that is leaving patients caught in the middle. At Bayonne Medical Center in New Jersey, Horizon Blue Cross Blue Shield delivered letters to patients at the hospital "warning that the patient would face a huge hospital bill if he did not leave right away."
For the 29,000 patients in the United States with metastatic colorectal cancer, chemotherapy with irinotecan is a standard treatment that has been shown to improve survival. But for more than one in 10 of these patients, a variation in their DNA means that this treatment could result in a severe reduction in their white blood cell count, leading to a high risk of bacterial infection and possible subsequent death.
› Verified 4 days ago
Alan L Thurman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 8200 Meadowbridge Rd Ste 301, Mechanicsville, VA 23116 Phone: 804-442-3750 Fax: 804-559-8535 | |
Dr. April N Obier, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8260 Atlee Rd, Mechanicsville, VA 23116 Phone: 804-764-6111 | |
Justin Guy Myers, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 8260 Atlee Road, Emergency Department, Mechanicsville, VA 23116 Phone: 804-569-7007 | |
Matthew Baltz, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8260 Atlee Rd, Mechanicsville, VA 23116 Phone: 240-686-2300 | |
Dr. Ralph H. Robertson, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 8260 Atlee Rd, Mechanicsville, VA 23116 Phone: 804-764-6111 | |
Dr. William Burke Best, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8260 Atlee Road, Mechanicsville, VA 23116 Phone: 804-764-6000 Fax: 804-764-6420 | |
Lauren Gregg, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8260 Atlee Rd, Memorial Regional Medical Center, Mechanicsville, VA 23116 Phone: 804-569-7007 Fax: 804-569-1772 |